TKNO
Alpha Teknova, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.79
+4.56%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.62x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.68x
- Price / sales
- 9.57x
- Price / cash flow
- -68.88x
Enterprise value
- Enterprise value
- $428.2M
- EV / sales
- 9.80x
- EV / EBITDA
- -45.26x
- EV / EBIT
- -27.08x
- Market cap
- $418.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026